Business

Novavax witnessed a surge in its stock price by 50% on Monday following a groundbreaking deal with French pharmaceutical giant, Sanofi. The deal, which was announced on Friday, not only doubled Novavax’s stock but also eliminated the company’s previous “going concern” warning, instilling hope in its stakeholders. This partnership has paved the way for Novavax
0 Comments
Moderna announced on Friday that the Food and Drug Administration (FDA) has postponed the approval of its vaccine for respiratory syncytial virus (RSV) to the end of May. This delay is reportedly due to “administrative constraints” at the agency, pushing back the expected decision date from Sunday. Despite this setback, the FDA has not raised
0 Comments
For the first time in over a decade, the summer movie season kicked off without a Marvel Cinematic Universe film, a shift that has had a noticeable impact on the box office. Usually, Marvel films have been the cornerstone of the summer season, consistently generating massive openings of over $100 million. However, this year, Universal’s
0 Comments
Disney has been gearing up for a significant shift in its business model, particularly focusing on its streaming services. The recent second-quarter results indicate a notable improvement in the financial performance of Disney’s streaming units. From a loss of $659 million a year ago to losing just $18 million this quarter, Disney+ Hulu, and ESPN+
0 Comments